This year, we make the International Biomedical Congress of Sofia a multidisciplinary event, including not only medicine, but its partner in medical care, namely Pharmacy !
The pharmaceutical symposium will deepen your knowledge with an innotive approach by combining incredibly intelligent keynotes and extremely interesting workshops.
Workshops - they are the most interactive part of the congress. You will be able to apply your theoretical knowledge into practice through our scientific workshops and evaluate your own skills. "Science is what makes you a pharmacist, but soft-skills make you a professional!" That is why we included soft-skills trainings - to present our participants with opportunities and allow their future growth!
Antony Dimitrov graduated the National High School of Science and Mathematics in Sofia, profile chemistry (1980), later, Sofia University, Faculty of Chemistry (1987). He holds a B.S. and M.Sci. in Chemistry from Sofia University and a Ph.D. in Physical Chemistry (995) from The University of Tokyo Dr. Dimitrov started his research carrier at Sofia University in 1987 with main subject on the properties of foams and emulsion From 1992 to 1995 he was a senior research associate at the Nagayama Protein Array Project in Japan with main subject on the formation of 2D arrays from small particles modeling large protein molecules. From 1995 to 1999 Dr. Dimitrov was a staff scientist at L'Oréal in Japan in a small team that established new research laboratory for L'Oréal in Tsukuba city, which was designed to become a link between L'Oréal Recherché an Tsukuba Research Consortium. From 1999 to 2004, Dr. Dimitrov was a post-doctoral fellow at the LECB, NCI, NIH in Maryland, USA, where by using a variety of methodologies like fluorescent microscopy, immunoprecipitation and co-immunoprecipitation, antibody staining, enzyme linked immuno-sorbent assay, etc., he studied HIV entry mechanism under the supervision of Dr. Robert P Blumenthal. From 2004 to 2006 Dr. Dimitrov was research associate at the Uniformed Services University of the Health Sciences (USUHS) in Maryland, USA, with main subject on developing soluble antigens for selecting novel antibodies against the emerging Hendra and Nipah viruses, both potential bioterror candidates. Dr. Dimitrov had a critical role in the discovery that EphrinB2 is the primary receptor for both Hendra and Nipah viruses Since 2006 Dr. Dimitrov is staff scientist at Profectus BioSciences, Inc. leading the efforts of discovering and developing antibodies to treat viral infections, mainly HIV Hendra and Nipah viruses. He has won number of NIH grant awards to financially support these activities. The two most advanced projects are on the prophylactics and treatment of henipavirus infections, subject to the present talk. Dr. Dimitrov has also edited a volume in the Methods Molecular Biology series-Therapeutic antibodies. Methods and protocols, Methods Mol. Biol. v. 525 March 2009, Humana Pres Springer, New York, NY 10013